The experience of going from a founder-owned organization of 90 people to being part of an organization of over 2,000 people is one that would not have been possible without the perspectives, industry knowledge, and expertise that Shane and the entire Crosstree team brought to bear on our transaction.

DAVE YOUNG
Founder & CEO
Trifecta Clinical

We needed to find a partner who would support our growth while allowing us to maintain our voice in strategy and goal setting and our commitment to personalized client interactions. Crosstree’s expertise and network in the biostatistics and CRO space helped us find CATO SMS, the perfect match of complementary culture, synergies, and strategy.

 

SANDY FERBER
CEO & President
Array Biostatistics

 

We were very impressed with [Crosstree’s] understanding of our business…specifically because we were under a 30-day closing timeline. They were a very dedicated team, working into the late hours of the night to be able to meet that deadline. I would highly recommend Crosstree as an investment banking choice.

LYNN MEYER
Founder and Managing Partner
IntegReview IRB

Crosstree’s specific knowledge of our market segment allowed them to precisely target potential buyers. Further, Crosstree guided management to the right “value drivers” for each potential buyer, optimally tuning our various presentations, and ultimately driving enhanced valuations during the auction process.

 

DOUG ENGFER
Founder, President, & CEO
invivodata, Inc.

Jeff and his colleagues at Crosstree did an exceptional job with our process.  We benefited greatly from their industry knowledge, expansive network, deal expertise and just plain hard work.  Most importantly, their bankers demonstrated sterling integrity and always gave us sound advice that resulted in an excellent outcome, despite numerous twists and turns along the way.

 

JIM PETRILLA
CEO & Co-Founder
BioAgilytix Labs, Inc.

We were impressed with the intensity and thoroughness of Crosstree’s preparation. Their team worked tirelessly on analytics and positioning, ultimately giving us the flexibility to efficiently navigate various strategic options involving our business and each of its two divisions. I wouldn’t think twice about using Crosstree again.

 

TODD GROSSHANDLER
Co-Founder
Enthalpy Analytical